Even if shifts occur within the anti-diabetes segment, such as therapies moving from the top to the bottom of the market ...

A man who says he got 'Ozempic penis' from the weight loss drug Wegovy has opened up on how his sex life has been going ...

Indianapolis-based Eli Lilly and Co. shares fell Thursday, Aug. 7 following the pharmaceutical company's second-quarter ...

Among them is Clinton Hall, a craft beer and burger joint in New York. The bar introduced its “teeny-weeny mini meal,” a bite ...

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount ...

With skinny jabs and shrinking waistlines becoming the new normal‭, ‬many fitness conscious are opting for smaller‭, ...

So many people in western countries are turning to weight loss drugs such as Wegovy/Ozempic and Mounjaro that concerns have ...

A recent study suggests that Eli Lilly's new weight-loss medication helped individuals lose significant amounts of ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

A new obesity pill, Orforglipron, shows promise in weight loss trials. Eli Lilly reports that patients lost around 12% of ...

LLY tumbles despite solid Q2 results. ETFs like IHE, PPH, MEDX and MEDI with top exposure may offer buy-the-dip opportunities.